Mode
Text Size
Log in / Sign up
Phase 4 N=42 Randomized Triple-blind Treatment

Effect of Deep Neuromuscular Block (NMB), Inhalation or TIVA on Pneumoperitoneum.

Muscle Relaxation

Enrolled (actual)
42
Serious AEs
2.4%
Results posted
May 2019
Primary outcome: Primary: Effect of Anesthetics on the Pressure at Zero Volume (PV0) Measured During Insufflation of the Abdomen — 5.7; 8.29; 6.58 mmHg

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
rocuronium (Drug); Sevoflurane (Drug); remifentanyl (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
AZ Sint-Jan AV
Primary completion
Dec 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Effect of Anesthetics on the Pressure at Zero Volume (PV0) Measured During Insufflation of the Abdomen
5.7; 8.29; 6.58
PRIMARY
Effect of Anesthetics on the Abdominal Elastance (E) Measured During Insufflation of the Abdomen by
2.53; 2.71; 2.5
SECONDARY
Adverse Events Difference Between the Three Groups
0; 0; 0

Summary

The objective of this study is to compare the value of deep neuromuscular block (NMB) (using rocuronium) in laparoscopy versus high dose opioids (using remifentanil) or 1 minimum alveolar concentration (MAC) inhalation (using sevoflurane) for the surgeon. The study hypothesis is that laparoscopic workspace is larger when using rocuronium versus opioids or inhalation. Laparoscopic workspace is measured as the abdominal compliance and the pressure at volume zero (PV0) using the abdominal pressure volume relation. Three points allow to calculate the abdominal compliance and the pressure at zero volume (PV0).

Eligibility Criteria

Inclusion Criteria

  • Laparoscopic bariatric surgery in a patient older than 18 years of age without previous laparotomy. Examples of laparoscopic bariatric procedures are gastric band, sleeve gastrectomy, gastric bypass, gastric bypass after lap band, and revision of a gastric bypass

Exclusion Criteria

  • Allergies or contraindications to the use of one or more of the following drugs: propofol, rocuronium, sugammadex, remifentanyl, or sevoflurane
  • History of a laparotomy
  • Emergency laparoscopy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01930747). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search